In our study of the PI3K/Akt/mTOR pathway, effector proteins represented by 70S6K, PRAS40, and PTEN are shown to be phosphoylated in the majority of AR-DLBCL cases. This evidence concerns the gene PTEN and diffuse large B-cell lymphoma.